HomeROVI • VIE
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€64.35
Day range
€63.60 - €64.35
Year range
€55.50 - €90.75
Market cap
3.19B EUR
Avg Volume
4.00
P/E ratio
20.17
Dividend yield
1.72%
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 235.28M | 9.93% |
Operating expense | 73.25M | 7.63% |
Net income | 69.15M | 32.51% |
Net profit margin | 29.39 | 20.55% |
Earnings per share | — | — |
EBITDA | 100.60M | 30.78% |
Effective tax rate | 22.62% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.55M | -68.86% |
Total assets | 877.85M | 5.67% |
Total liabilities | 319.66M | 15.78% |
Total equity | 558.19M | — |
Shares outstanding | 51.15M | — |
Price to book | 6.26 | — |
Return on assets | 25.95% | — |
Return on capital | 34.90% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 69.15M | 32.51% |
Cash from operations | 35.41M | 11,234.28% |
Cash from investing | -15.15M | -81.22% |
Cash from financing | -47.28M | 46.73% |
Net change in cash | -27.02M | 72.26% |
Free cash flow | -54.90M | 38.25% |
About
Founded
1946
Website
Employees
2,137
